Titles and Roles
- Assistant Professor, Department of Radiation Oncology
- Emory University School of Medicine
- Medical Student Clerkship Director
- Department of Radiation Oncology
- Adjunct Assistant Professor
- Georgia Institute of Technology
- Research Program
- Discovery and Developmental Therapeutics
Mohammad K. Khan, MD, PhD, specializes in the treatment of lymphoma, leukemia, multiple myeloma, skin (melanoma, squamous cell, basal cell, merkel cell), and pediatric cancers. Dr. Khan is board certified in Radiobiology/Physics ;by the American Board of Radiology.
Dr. Khan is a member of the American College of Radiology, American Brachytherapy Society, American Society for Therapeutic Radiation Oncology, American College of Radiation Oncology and American Society of Clinical Oncology. He serves as a board member of the Georgia Radiological Society; is a vice chair of the Radiation Safety Committee for Human Use at Emory; and is an active member of the ACRIN/ECOG melanoma committee. He is also the Panel Chair for the leukemia/lymphoma section of the Radiation Oncology In-Training Examination (TXIT™) program at the American College of Radiology. He also serves on the radiation oncology exam committee of the American Board of Radiology where he is involved developing maintenance of certification exam questions, initial certification exam questions, and oral exam questions as they relate to the management of lymphoma, leukemia, and myeloma patients.
Dr. Khan fluently speaks English, Urdu, Hindi and is familiar with Spanish and Arabic.
Prior to medical school, Dr. Khan received two BS degrees, one in Nuclear Engineering and one in Biology with a minor in Biochemistry & Molecular Biology. Both degrees were awarded with Summa Cum Laude distinction. He then completed his MS, and PhD degrees in Nuclear Engineering with emphasis on health and medical physics from the University of Tennessee, Knoxville. His graduate research focused on the use of innovative imaging technologies, such as PET and MRI, to improve radiation treatment planning for emerging cancer therapeutics such as boron neutron capture therapy for patients with malignant brain tumors.
Dr. Khan did his residency training in radiation oncology at the Cleveland Clinic, Cleveland, OH. He completed a fellowship in ABS Prostate Bracytherapy at the Seattle Prostate Institute and an internship in medicine and surgery at the Cleveland Clinic.
Dr. Khan continues to be actively engaged in a wide variety of cancer related research, including designing new clinical trials, enrolling patients on existing trials, developing patient databases to look at treatment outcomes, and engineering new mathematical and physics solutions to improve existing technologies such as IMRT (Intensity Modulated Radiotherapy) and IGRT (Image Guided Radiotherapy).
Below is a listing of current federal grants for the above principal investigator.
Dr. Khan has collectively authored over 73 abstracts, manuscripts, commentaries, and book chapters. He has presented at national and international conferences.
Publications Publication Date
During his residency training, he received several academic accolades including the Roentgen Resident/Fellow Research Award for Outstanding Radiological Research, the Scott Hamilton CARES Initiative Research Grant to fund a prospective phase I prostate cancer IGRT study, American College of Radiation Oncology Travel Award, American Brachytherapy Society Fellowship Award, and the American Society of Therapeutic Radiation Oncology Translation and Imaging Symposium Travel Award.